Liu, Xiaohuan
Zhang, Ying
Zhao, Li-ling
Duan, Yale
Hu, Zhizhen
Bao, Liya
Jin, Ping https://orcid.org/0000-0002-7835-076X
Funding for this research was provided by:
China International Medical Foundation (Z-2017-26-1902-5)
Jiangsu Hansoh Pharmaceutical Co Ltd
Article History
Received: 19 February 2025
Accepted: 25 March 2025
First Online: 11 April 2025
Change Date: 18 June 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s13300-025-01757-0
Declarations
:
: Yale Duan, Zhizhen Hu, and Liya Bao are employed by Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Xiaohuan Lin, Ying Zhang, Li-ling Zhao, and Ping Jin declare no competing interests.
: The study was approved by the Ethics Committee of The Third Xiangya Hospital of Central South University (Ethical Approval No. 24572) and exempted from obtaining patient informed consent. Consent to publish the results was obtained. The study was carried out in accordance with the Declaration of Helsinki and is registered in ClinicalTrials.gov (ChiCTR2400086699).